Climb Bio, Inc

Eliem Therapeutics, Inc is a biopharmaceutical company based in Redmond, WA, dedicated to rethinking treatment for nervous system disorders. With a focus on neuronal excitability disorders, such as chronic pain, depression, epilepsy, and anxiety, Eliem aims to develop novel therapies based on clinically validated mechanisms of action to empower patients to live happier and more fulfilling lives.

Driven by a team of experienced industry executives and advised by a board with considerable neurology research and development experience, Eliem is committed to delivering innovative therapies that provide relief and hope for the millions of patients affected by neurological conditions. Their pipeline includes ETX-155, a potential best-in-class treatment for major depressive disorder and focal onset seizures, designed to overcome the limitations of existing therapies and meet high unmet clinical needs.

Generated from the website